Cat. No.: X24-08-YM250
Microtubule/Tubulin inhibitor, Mal-PEG2-VCP-eribulin, Purity ≥98%
Synonym: 2130869-18-8; Mal-PEG2-VC-PAB-eribulin; [4-[[(2S)-5-(Carbamoylamino)-2-[[(2S)-2-[3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-[(2S)-2-hydroxy-3-[(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-21-methoxy-14-methyl-8,15-dimethylidene-24-oxo-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-20-yl]propyl]carbamate
- CAS Number: 2130869-18-8
- Compound CID: 138911392
Product Size
1 mg; 2 mg; 5 mg; 10 mg
Properties
Description
Mal-PEG2-VCP-eribulin is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Formula
C70H99N7O21
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Mal-PEG2-VCP-eribulin is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of cancer.
Related Products
- Microtubule/Tubulin inhibitor, Monomethyl auristatin E, Purity ≥98%
- Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%
- Microtubule/Tubulin inhibitor, Albendazole, Purity ≥98%
- Microtubule/Tubulin inhibitor, Chloroxine, Purity ≥98%
- Microtubule/Tubulin inhibitor, CYT997, Purity ≥98%
- Microtubule/Tubulin inhibitor, Epothilone A, Purity ≥98%
